BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23145068)

  • 1. The subthalamic microlesion story in Parkinson's disease: electrode insertion-related motor improvement with relative cortico-subcortical hypoactivation in fMRI.
    Jech R; Mueller K; Urgošík D; Sieger T; Holiga Š; Růžička F; Dušek P; Havránková P; Vymazal J; Růžička E
    PLoS One; 2012; 7(11):e49056. PubMed ID: 23145068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstem.
    Holiga Š; Mueller K; Möller HE; Urgošík D; Růžička E; Schroeter ML; Jech R
    Neuroimage Clin; 2015; 9():264-74. PubMed ID: 26509113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alleviation of off-period dystonia in Parkinson disease by a microlesion following subthalamic implantation.
    Derrey S; Lefaucheur R; Chastan N; Gérardin E; Hannequin D; Desbordes M; Maltête D
    J Neurosurg; 2010 Jun; 112(6):1263-6. PubMed ID: 19877801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia.
    Chung JW; Burciu RG; Ofori E; Coombes SA; Christou EA; Okun MS; Hess CW; Vaillancourt DE
    Neuroimage Clin; 2018; 19():559-571. PubMed ID: 29984164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
    Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
    Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus.
    Mirzadeh Z; Chapple K; Lambert M; Evidente VG; Mahant P; Ospina MC; Samanta J; Moguel-Cobos G; Salins N; Lieberman A; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2016 Apr; 124(4):902-7. PubMed ID: 26452116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain penetration effects of microelectrodes and DBS leads in STN or GPi.
    Mann JM; Foote KD; Garvan CW; Fernandez HH; Jacobson CE; Rodriguez RL; Haq IU; Siddiqui MS; Malaty IA; Morishita T; Hass CJ; Okun MS
    J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):794-7. PubMed ID: 19237386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of globus pallidus deep brain stimulation for Parkinson disease: a comparison of intraoperative MRI- and MER-guided lead placement.
    Bezchlibnyk YB; Sharma VD; Naik KB; Isbaine F; Gale JT; Cheng J; Triche SD; Miocinovic S; Buetefisch CM; Willie JT; Boulis NM; Factor SA; Wichmann T; DeLong MR; Gross RE
    J Neurosurg; 2020 Mar; 134(3):1072-1082. PubMed ID: 32114534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microlesion effect as a predictor of the effectiveness of subthalamic deep brain stimulation for Parkinson's disease.
    Tykocki T; Nauman P; Koziara H; Mandat T
    Stereotact Funct Neurosurg; 2013; 91(1):12-7. PubMed ID: 23154788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
    Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
    Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep brain stimulation outcomes in patients implanted under general anesthesia with frame-based stereotaxy and intraoperative MRI.
    Matias CM; Frizon LA; Nagel SJ; Lobel DA; Machado AG
    J Neurosurg; 2018 Dec; 129(6):1572-1578. PubMed ID: 29372880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous bilateral stereotactic procedure for deep brain stimulation implants: a significant step for reducing operation time.
    Fonoff ET; Azevedo A; Angelos JS; Martinez RC; Navarro J; Reis PR; Sepulveda ME; Cury RG; Ghilardi MG; Teixeira MJ; Lopez WO
    J Neurosurg; 2016 Jul; 125(1):85-9. PubMed ID: 26684776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.
    ; Obeso JA; Olanow CW; Rodriguez-Oroz MC; Krack P; Kumar R; Lang AE
    N Engl J Med; 2001 Sep; 345(13):956-63. PubMed ID: 11575287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic nucleus and globus pallidus internus stimulation for the treatment of Parkinson's disease: A systematic review.
    Xu H; Zheng F; Krischek B; Ding W; Xiong C; Wang X; Niu C
    J Int Med Res; 2017 Oct; 45(5):1602-1612. PubMed ID: 28701061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.